Loading...
XJSELHC
Market cap1.31bUSD
Dec 20, Last price  
1,664.00ZAR
1D
0.18%
1Q
4.72%
Jan 2017
-45.14%
Name

Life Healthcare Group Holdings Ltd

Chart & Performance

D1W1MN
XJSE:LHC chart
P/E
9,089.57
P/S
105.99
EPS
0.18
Div Yield, %
0.03%
Shrs. gr., 5y
—
Rev. gr., 5y
-0.73%
Revenues
25.52b
+12.71%
7,929,667,0008,786,334,0009,811,964,00010,937,000,00011,843,000,00013,046,000,00014,647,000,00016,404,000,00020,797,000,00023,488,000,00025,672,000,00025,386,000,00026,885,000,00028,206,000,00022,641,000,00025,519,000,000
Net income
4.83b
+1,728.41%
759,376,000664,321,0001,287,000,0001,496,000,0001,711,000,0002,774,000,0001,866,000,0001,616,000,000814,000,0001,575,000,0002,569,000,000-93,000,0001,754,000,0001,531,000,000264,000,0004,827,000,000
CFO
3.72b
-20.28%
1,402,051,0001,837,026,0001,945,891,0002,294,000,0002,610,000,0002,536,000,0002,939,000,0003,055,000,0003,724,000,0004,440,000,0004,655,000,0004,041,000,0005,142,000,0004,232,000,0004,670,000,0003,723,000,000
Dividend
Jun 12, 202419 ZAR/sh
Earnings
Feb 21, 2025

Profile

Life Healthcare Group Holdings Limited, together with its subsidiaries, operates private hospitals in South Africa, Canada, the United Kingdom, rest of Europe, and Internationally. It operates through two segments, Hospitals and Complementary Services; and Healthcare Services. The company provides range of acute hospitals and complementary services; Life Esidimeni services, such as chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, and primary healthcare and substance abuse recovery programs; and life employee health solutions, including on-site occupational and primary healthcare services and employee wellness programs. It also offers services in the areas of diagnostics, mental health, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedic, pediatric, dermatology, ophthalmology, gynecology, and obstetric. In addition, the company provides diagnostic imaging services; magnetic resonance imaging and computerized tomography scanners; develops, manufactures, and distributes radiopharmaceuticals for use in positron emission tomography-computerized tomography (PET-CT) diagnostics. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.
URL
https://www.lifehealthcare.co.za/
IPO date
Jul 02, 1905
Employees
Domiciled in
ZA
Incorporated in
ZA

Valuation

Title
ZAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
25,519,000
12.71%
22,641,000
-19.73%
28,206,000
4.91%
Cost of revenue
9,148,000
18,282,000
10,092,000
Unusual Expense (Income)
NOPBT
16,371,000
4,359,000
18,114,000
NOPBT Margin
64.15%
19.25%
64.22%
Operating Taxes
538,000
483,000
768,000
Tax Rate
3.29%
11.08%
4.24%
NOPAT
15,833,000
3,876,000
17,346,000
Net income
4,827,000
1,728.41%
264,000
-82.76%
1,531,000
-12.71%
Dividends
(9,472,000)
(616,000)
(587,000)
Dividend yield
Proceeds from repurchase of equity
(277,000)
(121,000)
3,249,000
BB yield
Debt
Debt current
1,027,000
2,179,000
1,561,000
Long-term debt
4,543,000
12,126,000
14,619,000
Deferred revenue
410,000
Other long-term liabilities
674,000
2,118,000
425,000
Net debt
3,108,000
13,453,000
12,907,000
Cash flow
Cash from operating activities
3,723,000
4,670,000
4,232,000
CAPEX
(1,338,000)
(1,213,000)
(2,348,000)
Cash from investing activities
16,664,000
(2,933,000)
(2,703,000)
Cash from financing activities
(19,622,000)
(2,628,000)
(1,407,000)
FCF
34,295,000
(10,807,000)
16,475,000
Balance
Cash
2,462,000
846,000
2,802,000
Long term investments
6,000
471,000
Excess cash
1,186,050
1,862,700
Stockholders' equity
11,149,000
15,894,000
17,025,000
Invested Capital
17,422,950
36,596,000
32,317,300
ROIC
58.62%
11.25%
54.62%
ROCE
81.44%
11.91%
50.39%
EV
Common stock shares outstanding
1,454,020
363,504
Price
Market cap
EV
EBITDA
17,645,000
5,485,000
20,327,000
EV/EBITDA
Interest
422,000
578,000
644,000
Interest/NOPBT
2.58%
13.26%
3.56%